1041 DEVELOPMENT OF A NOMOGRAM TO PREDICT INDIVIDUAL BENEFIT ATTAINED FROM ADDITION OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF STAGE II COLON CANCER

Clay M. Merritt, Shu-Ching Chang, Gary L. Grunkemeier, Scott Steele, Melanie Goldfarb, Daniel Nelson

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalGastroenterology
Volume158
DOIs
StatePublished - May 1 2020

Disciplines

  • Oncology
  • Internal Medicine
  • Medicine and Health Sciences

Cite this